Rejuversen

Rejuversen is a pioneering biotechnology research company focused on discovering and developing innovative therapies for diseases driven by senescence. With a commitment to addressing age-related diseases associated with fibrosis and oncology, Rejuversen is dedicated to advancing medical science and improving patient outcomes.

Located in Barcelona, ES (Primary address) and Baar, CH, Rejuversen operates with a dedicated team of experts driving advancements in the field of senescence-targeted therapeutics. The company's research efforts are geared towards creating novel medicines that can make a significant impact on the lives of individuals affected by these challenging conditions. Rejuversen is committed to innovation and excellence in all its endeavors.

Rejuversen aims to be at the forefront of biotechnology, consistently pushing the boundaries of what's possible in disease treatment. We invite the management of Rejuversen to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and attract potential partners and investors.